Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8091)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2019 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang MW, Fu XL, Jiang YS, Chen XJ, Tao LY, Yang JY, Huo YM, Liu W, Zhang JF, Liu PF, Liu Q, Hua R, Zhang ZG, Sun YW, Liu DJ. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas. World J Gastroenterol 2019; 25(14): 1684-1696 [PMID: 31011254 DOI: 10.3748/wjg.v25.i14.1684] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i14/1684.htm |
| Number | Citing Articles |
| 1 |
Erik Rösner, Daniel Kaemmerer, Jörg Sänger, Amelie Lupp. Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data. Translational Oncology 2022; 25: 101526 doi: 10.1016/j.tranon.2022.101526
|
| 2 |
Jiazhang Xing, Jingci Chen, Tingting You, Zhao Sun, Tao Lu, Yuejuan Cheng, Huanwen Wu, Chunmei Bai. Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis. Journal of Neuroendocrinology 2023; 35(4) doi: 10.1111/jne.13257
|
| 3 |
Alexander W. MacFarlane, Ho-Man Yeung, R. Katherine Alpaugh, Essel Dulaimi, Paul F. Engstrom, Arvind Dasari, Kerry S. Campbell, Namrata Vijayvergia. Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms. Cancer Immunology, Immunotherapy 2021; 70(7): 1893 doi: 10.1007/s00262-020-02811-5
|
| 4 |
Z Liu, F Mi, M Han, M Tian, L Deng, N Meng, J Luo, R Fu. Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma. Clinical and Experimental Immunology 2021; 205(1): 53 doi: 10.1111/cei.13594
|
| 5 |
Ilaria Maggio, Lisa Manuzzi, Giuseppe Lamberti, Angela Dalia Ricci, Nastassja Tober, Davide Campana. Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia. Cancers 2020; 12(4): 832 doi: 10.3390/cancers12040832
|
| 6 |
Satoshi Yamashita, Hiroyuki Abe, Akiko Kunita, Hiroharu Yamashita, Yasuyuki Seto, Tetsuo Ushiku. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma. Histopathology 2021; 78(3): 381 doi: 10.1111/his.14230
|
| 7 |
He Fei, Ze-Feng Li, Ying-Tai Chen, Dong-Bing Zhao. Hepatoid adenocarcinoma of the stomach with neuroendocrine differentiation: A case report and review of literature. World Journal of Clinical Cases 2023; 11(22): 5323 doi: 10.12998/wjcc.v11.i22.5323
|
| 8 |
Virginia Corbett, Susanne Arnold, Lowell Anthony, Aman Chauhan. Management of Large Cell Neuroendocrine Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.653162
|
| 9 |
Mengyuan Liu, Elizabeta C. Popa, Brendan M. Finnerty, Thomas J. Fahey, Rasa Zarnegar. Clinicopathological Features of Gastroesophageal Neuroendocrine Neoplasms. Current Gastroenterology Reports 2020; 22(10) doi: 10.1007/s11894-020-00788-w
|
| 10 |
He Fei, Ze-Feng Li, Ying-Tai Chen, Dong-Bing Zhao. Hepatoid adenocarcinoma of the stomach with neuroendocrine differentiation: A case report and review of literature. World Journal of Clinical Cases 2023; 11(22): 5329-5337 doi: 10.12998/wjcc.v11.i22.5329
Abstract(423) |
Core Tip(361) |
Full Article(HTML)(1596)
|
Full Article with Cover (PDF)-11039K(64)
|
Full Article (Word)-1750K(26)
|
Audio-618K(5)
|
Peer-Review Report-223K(34)
|
Answering Reviewers-98K(36)
|
Full Article (PDF)-10700K(122)
|
Full Article (XML)-147K(41)
|
Times Cited (2)
|
Total Visits (4243)
|
Open
|
| 11 |
Zhuo Han, Nan Wang, Qing Qiao, Xianli He, Nan Wang. Association of PD-L1 Expression with Clinicopathologic Characters
in Gastric Cancer: A Comprehensive Meta-analysis. Current Medicinal Chemistry 2024; 31(21): 3198 doi: 10.2174/0109298673263784230922060257
|
| 12 |
Melissa Frizziero, Elaine Kilgour, Kathryn L. Simpson, Dominic G. Rothwell, David A. Moore, Kristopher K. Frese, Melanie Galvin, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Mairéad G. McNamara, Caroline Dive. Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma. Clinical Cancer Research 2022; 28(10): 1999 doi: 10.1158/1078-0432.CCR-21-3058
|
| 13 |
Guanghui Xu, Yuhao Wang, Hushan Zhang, Xueke She, Jianjun Yang. Immunotherapy and Potential Predictive Biomarkers in the Treatment of Neuroendocrine Neoplasia. Future Oncology 2021; 17(9): 1069 doi: 10.2217/fon-2020-0703
|
| 14 |
Caroline Lum, Sophia Frentzas. Research and Clinical Applications of Targeting Gastric Neoplasms. 2021; : 317 doi: 10.1016/B978-0-323-85563-1.00010-1
|
| 15 |
Sevil Karabağ, Meltem Öznur. PD-L1, MMR, and EGFR expression in gastrointestinal neuroendocrine tumors. Cukurova Medical Journal 2024; 49(2): 400 doi: 10.17826/cumj.1445549
|
| 16 |
Shuaishuai Xu, Chanqi Ye, Ruyin Chen, Qiong Li, Jian Ruan. The Landscape and Clinical Application of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers 2022; 14(12): 2911 doi: 10.3390/cancers14122911
|
| 17 |
Eléonore Multone, Stefano La Rosa, Christine Sempoux, Silvia Uccella. PD-L1 expression, tumor-infiltrating lymphocytes, and mismatch repair proteins status in digestive neuroendocrine neoplasms: exploring their potential role as theragnostic and prognostic biomarkers. Virchows Archiv 2024; 485(5): 841 doi: 10.1007/s00428-024-03825-5
|
| 18 |
Ze-Feng Li, Hai-Zhen Lu, Ying-Tai Chen, Xiao-Feng Bai, Tong-Bo Wang, He Fei, Dong-Bing Zhao. Mixed large and small cell neuroendocrine carcinoma of the stomach: A case report and review of literature. World Journal of Clinical Cases 2022; 10(16): 5502-5509 doi: 10.12998/wjcc.v10.i16.5502
|
| 19 |
Jiazhang Xing, Hongyan Ying, Ji Li, Yang Gao, Zhao Sun, Jiarui Li, Chunmei Bai, Yuejuan Cheng, Huanwen Wu. Immune Checkpoint Markers in Neuroendocrine Carcinoma of the Digestive System. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00132
|
| 20 |
Ping Zhou, Yiyun Fu, Weiya Wang. Case Report: Gastrointestinal neuroendocrine carcinoma with SMARCA4 deficiency: a clinicopathological report of two rare cases. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1290717
|
| 21 |
Chunyan Hu, Shu Tian, Lan Lin, Jiahao Zhang, Hao Ding. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma. Oral Oncology 2020; 102: 104560 doi: 10.1016/j.oraloncology.2019.104560
|
| 22 |
Klaire Exarchou, Nathan A. Stephens, Andrew R. Moore, Nathan R. Howes, D. Mark Pritchard. New Developments in Gastric Neuroendocrine Neoplasms. Current Oncology Reports 2022; 24(1): 77 doi: 10.1007/s11912-021-01175-y
|
| 23 |
Krzysztof Kaliszewski, Maksymilian Ludwig, Maria Greniuk, Agnieszka Mikuła, Karol Zagórski, Jerzy Rudnicki. Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Cancers 2022; 14(8): 2028 doi: 10.3390/cancers14082028
|
| 24 |
Wei Liu, Lei Zhang, Zhiming Xiu, Jian Guo, Liye Wang, Yue Zhou, Yang Jiao, Meiyan Sun, Jianhui Cai. <p>Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer</p>. OncoTargets and Therapy 2020; : 7229 doi: 10.2147/OTT.S255491
|
| 25 |
Anja Rinke, Christoph J Auernhammer, Lisa Bodei, Mark Kidd, Sebastian Krug, Rita Lawlor, Ilaria Marinoni, Aurel Perren, Aldo Scarpa, Halfdan Sorbye, Marianne Ellen Pavel, Matthias M Weber, Irvin Modlin, Thomas M Gress. Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?. Gut 2021; 70(9): 1768 doi: 10.1136/gutjnl-2020-321300
|
| 26 |
Michele Prisciandaro, Maria Antista, Alessandra Raimondi, Francesca Corti, Federica Morano, Giovanni Centonze, Giovanna Sabella, Alessandro Mangogna, Giovanni Randon, Filippo Pagani, Natalie Prinzi, Monica Niger, Salvatore Corallo, Erica Castiglioni di Caronno, Marco Massafra, Maria Di Bartolomeo, Filippo de Braud, Massimo Milione, Sara Pusceddu. Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.780716
|
| 27 |
Ioana Rada Popa Ilie, Carmen Emanuela Georgescu. Immunotherapy in Gastroenteropancreatic Neuroendocrine Neoplasia. Neuroendocrinology 2023; 113(2): 262 doi: 10.1159/000518106
|
| 28 |
Li Chen, Shaolong Huang, Qiang Liu, Xiangyi Kong, Zhaohui Su, Mengliu Zhu, Yi Fang, Lin Zhang, Xingrui Li, Jing Wang. PD-L1 Protein Expression Is Associated With Good Clinical Outcomes and Nomogram for Prediction of Disease Free Survival and Overall Survival in Breast Cancer Patients Received Neoadjuvant Chemotherapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.849468
|